not justify Dr Field's well known views, he rejects the observations without, in fact, backing up his views with objective evidence.
Contrary to Dr Field's statement that it is characteristic for the complaints in question to be exhibited after a latent period, such has not been the documented evidence in those patients reported on in my studies. This would suggest that Dr Field's population, coming as it does, I believe, mainly from insurance companies, may be a selected one.
Finally, in answer to the question in the first sentence of the second paragraph, those symptoms that are clearly those of a reactive depression certainly may follow any injury, as indeed they do following labour and operations on the body for all sorts of causes and other noncompensation able traumata. He is futhermore quite correct in his assumption that as a neurologist I never see a positional vertigo in a hitherto healthy miner who has had injury to a peripheral part of his body. It would be interesting to know Dr Field's figures and the number of times he has met this symptom in such people.
May I repeat the explanation for carrying out this work which I gave when I delivered the first Sandoz lecture on this subject over ten years ago. Because the views expressed by Henry Miller et al. appeared to be contrary to the clinical impressions of many others, I started to carry out and I finished a prospective study of symptoms, the course and the final state of every patient referred to me since 1963 suffering from any kind of head injury; the report published was on all of those patients who developed the post-traumatic syndrome. It had been my hope that when presented with these accurately collected data, our colleagues would cease expressing contrary views unless they had made an equally long-term study and were in a position to produce figures to backup their views that appeared to many of us to be prejudices rather than the results of observations based on scientifically collected data. (Dally 1969) .It has been shown that in animals the stimulation of enkephalin receptors in the chemoreceptor trigger zone causes vomiting which can be inhibited by Nx at low doses (Bhargava et al. 1981) . It is therefore possible that the weight gain in these cases was directly related to this effect, although no mention of this factor is made by these authors.
Since noradrenalin reverses AN in animals with hypothalamic damage, which effect is suppressed by alpha-adrenergic blockers, it has been suggested that the noradrenergic feeding system is a component of the ascending noradrenergic reward system. Furthermore, activating the noradrenergic feeding system of amphetaminetreated rats by intraventricular treatment with noradrenalin also prevents anorexia (Berger et 01. 1971) . Recently, the alpha-noradrenergic agonist clonidine has been shown to cause hyperphagia and weight gain in monkeys and hence this drug was suggested as a possible treatment for AN (Schlemmer et al. 1979 ).
The noradrenergic system has been implicated in the stimulation of the release of LH-RH in the arcuate median eminence region of the hypothalamus, while alpha-adrenergic blockers inhibit LH release (McCann 1977) .
This shows the possible connection between amenorrhoea and anorexia in cases of AN. Patients with AN have been found not to respond normally to exogenous LH-RH by a rise of LH and FSH in the blood Walmer et 01. 1975) . This indicates the possibility of an inhibitory factor being present to prevent the normal response. Nx increases the LH in normal subjects (Moult et 01. 1981) , which implies that the release of LH is under opioid inhibitory control. In addition, Nx was able to increase LH in cases of amenorrhoea (Blankstein et al. 1981) .
These data indicate that there are inhibitory opioid pathways involved in LH secretion; in fact, these authors further suggest that an overproduction of opioids may play a role in some cases of amenorrhoea (Blankstein et 01. 1981) .
In cases of AN there may well be an excess production of opioids. This would indicate the possiblity that the opiate antagonists may well have a role in the therapy of AN, since they would help to overcome the presynaptic opioid inhibition of LH-RH release, thus raising LH levels to more normal values. 
Mapping neuronal electrical function From Dr A B Joseph University of Cambridge School of Clinical Medicine
Sir, In the editorial 'Surgery for stroke' (May Journal. p 330), the use ofextra-intracranial bypass surgery to improve established neurological deficit after cerebral infarction is discussed. The difficulty of measuring operative success is mentioned: 'Claims ofimprovement in neurological deficit have been made in completed strokes, but the very variable natural history of the acute deficit due to recent infarction and the difficulty of accurate subjective assessment of deficit make such claims difficult to evaluate'. This difficulty could be overcome if a technique for mapping areas of brain undergoing reversible ischaemia, but not cell death, were available. In addition, the criteria for attempting revascularization could be made more objective.
Two approaches to the problem, which depend on the convergence of recent developments in physiology, electroencephalography and physics, are outlined below.
It is known that neurons are potentially viable for some time after the onset of acute ischaemia. If revascularization could be accomplished during this period, neurological deficit due to infarction might be lessened or prevented (Joseph 1979) .
Brain electrical activity monitoring (BEAM) is a way of mapping global neuronal electrical function. It was originally devised as an improved form of electroencephalography (EEG) and was able to localize tumours in patients with normal or nondiagnostic EEGs (Duffy et al. 1979 ). Since then, BEAM has been used to map regions of aberrant electrophysiology in dyslexics (Duffy et al. 1980a) . That BEAM can detect anatomically delineated areas of abnormality in what is often considered a functional disorder suggests that it should also be sensitive to regions of reversible ischaemia, and thus able to provide both an indication for brain revascularization and an objective way of measuring postoperative neurological improvement.
• A further refinement exists. Duffy et al. (1980b) have devised a procedure for the automated diagnosis of dyslexia based on BEAM. This could serve as the model for a similar system to detect reversible ischaemia.
Another approach to the problem is made possible by new advances in physics.
Barker (1981, personal communication) is developing microelectric circuitry several orders of magnitude smaller than present microchip elements. Theoretically these would enable multiple inputoutput electrodes to be placed on a single cell, allowing the functional neurophysiological mapping of whole fields of neurons (Joseph, in preparation) . Multiple electrode arrays using conventional electronic elements are already proving useful in providing rudimentary artificial vision and hearing (Do belle et al. 1973 , Dobelle 1977 , Joseph 1981 , and with the new, denselypacked circuitry could be adapted to detect reversible ischaemia.
The techniques described' above, or other similar ones, should allow brain revascularization to become a routine procedure which is based on objective criteria and assessed postoperatively by functional mapping. Purple toe syndrome From Mr C A Akle & Dr C L Joiner Guy's Hospital, London SE1 9RT Dear Sir, The suggestion by Dr Nassar (July Journal. p 557) of necrotizing angiitis causing Raynaud's phenomenon is not applicable to our case (March, p 219). As the classic sequence of events of Raynaud's did not occur and the colour change was permanent, it is certain that this is not the cause. Although a biopsy was not done, our case fulfilled the criteria of the cases described by Feder & Auerbach (1961) in whom biopsies did not show any sign of vasculitis, but rather capillary dilatation. The location of the lesions and their persistence over several years in the absence of vasculitis elsewhere make a diagnosis of necrotizing angiitis unlikely.
The role of heparin in the symptomatic relief is unlikely as the patient described similar relief on
